KATHMANDU, Jan 15 (Reuters) - Nepal on Friday granted
approval for AstraZeneca's COVISHIELD vaccine against
the novel coronavirus in the country.
"Conditional permission has been granted for emergency use
authorization of COVISHIELD vaccine against COVID-19 in Nepal,"
a statement by the country's Department of Drug Administration
said.
Nepal has reported 266,816 cases and 1,948 deaths from
COVID-19 so far, according to official data.
(Reporting by Gopal Sharma; Writing by Alasdair Pal; Editing by
Jan Harvey)
Astrazeneca (AZN)
